Unipolar depression and Psoriasis


Psoriasis is found among people with Unipolar depression, especially for people who are female, 50-59 old.

The study analyzes which people have Psoriasis with Unipolar depression. It is created by eHealthMe based on reports of 16 people who have Unipolar depression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 04, 2022

16 people who have Unipolar Depression and Psoriasis are studied.

What is Unipolar depression?

Unipolar depression is found to be associated with 1,937 drugs and 1,367 conditions by eHealthMe.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,212 drugs and 1,570 conditions by eHealthMe.

Number of Psoriasis in Unipolar depression reports submitted per year:

Would you have Psoriasis when you have Unipolar depression?

Gender of people who have Unipolar Depression and experienced Psoriasis *:

  • female: 73.33 %
  • male: 26.67 %

Age of people who have Unipolar Depression and experienced Psoriasis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 9.09 %
  • 40-49: 18.18 %
  • 50-59: 45.45 %
  • 60+: 27.27 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 5 people, 31.25%
  2. Sleep Disorder: 4 people, 25.00%
  3. Depression: 4 people, 25.00%
  4. Sleep Walking (walking during sleep): 2 people, 12.50%
  5. Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 2 people, 12.50%
  6. Prostatic Disorder: 2 people, 12.50%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 12.50%
  8. Migraine (headache): 2 people, 12.50%
  9. Irritable Bowel Syndrome: 2 people, 12.50%
  10. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 12.50%

Common drugs taken by these people *:

  1. Wellbutrin: 3 people, 18.75%
  2. Humira: 3 people, 18.75%
  3. Melatonin: 2 people, 12.50%
  4. Memantine: 2 people, 12.50%
  5. Clonazepam: 2 people, 12.50%
  6. Cosentyx: 2 people, 12.50%
  7. Cyclosporine: 2 people, 12.50%
  8. Dapsone: 2 people, 12.50%
  9. Effexor: 2 people, 12.50%
  10. Finasteride: 2 people, 12.50%

Common symptoms for these people *:

  1. White Blood Cell Count Decreased: 2 people, 12.50%
  2. Scar Pain: 2 people, 12.50%
  3. Drug Ineffective: 2 people, 12.50%
  4. Headache (pain in head): 2 people, 12.50%
  5. Itching: 2 people, 12.50%
  6. Anaemia (lack of blood): 2 people, 12.50%
  7. Hypoaesthesia (reduced sense of touch or sensation): 1 person, 6.25%
  8. Ankle Fracture: 1 person, 6.25%
  9. Burning Sensation: 1 person, 6.25%
  10. Diarrhea Haemorrhagic: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Psoriasis?

Check whether Psoriasis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Psoriasis:

Common drugs associated with Psoriasis:

All the drugs that are associated with Psoriasis:

Common conditions associated with Psoriasis:

All the conditions that are associated with Psoriasis:

How the study uses the data?

The study is based on Psoriasis and Unipolar depression, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: